Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PDGFR Tyrosine Kinase Inhibitor VI, SU6668 (CAS 210644-62-5)

5.0(1)
Write a reviewAsk a question

See product citations (9)

Application:
PDGFR Tyrosine Kinase Inhibitor VI, SU6668 is a potent ATP-competitive inhibitor against tyrosine kinases
CAS Number:
210644-62-5
Purity:
>97%
Molecular Weight:
310.4
Molecular Formula:
C18H18N2O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PDGFR Tyrosine Kinase Inhibitor VI, SU6668 is a cell-permeable indolinone compound that acts as a potent ATP-competitive inhibitor against RTKs (receptor tyrosine kinases) Kit, PDGFRb, VEGFR2 (Flk-1/KDR), FGFR1 activity in vitro (IC50 = 0.01, 0.1, 3.9, and 3.8 µM, respectively) and PDGF/VEGF/bFGF-mediated angiogenesis and tumor development. Although initially characterized as an RTK inhibitor, SU6668 is now also known to target ser/thr kinases Aurora A, Aurora B, TBK1 (NAK/T2K), and AMPK (IC50 = 0.85, 0.047, 1.4, and 1.8 µM, respectively), as well as non-receptor TKs Lyn and Yes (IC50 = 4.3 and 5.8 µM, respectively).

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PDGFR Tyrosine Kinase Inhibitor VI, SU6668, 5 mg

sc-204175
5 mg
$79.00